Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda PharmaceuticalfiledCriticalTakeda Pharmaceutical
Priority claimed from PCT/US2011/068235external-prioritypatent/WO2012092612A1/en
Publication of UA110226C2publicationCriticalpatent/UA110226C2/en
Винахід належить до антитіла проти CD38 людини (SEQ ID NO: 1) та СD38 яванського макака (SEQ ID NO: 2), виділеної нуклеїнової кислоти, клітини-хазяїна, способу одержання зазначеного антитіла та способу лікування за допомогою вказаних антитіл.The invention relates to antibodies against human CD38 (SEQ ID NO: 1) and CD38 cynomolgus macaque (SEQ ID NO: 2), a selected nucleic acid, a host cell, a method for producing said antibody and a method of treatment using said antibodies.
UAA201308436A2010-12-302011-12-30Antibodies to cd38
UA110226C2
(en)
"antibody, pharmaceutical composition, use of an antibody, method of treatment, nucleic acid, expression vector, host cell and method of producing a recombinant antibody"